(Q28217267)

Stefano Pini

4

0 references

Liliana Dell'Osso

2

Liliana Dell'Osso

0 references

Patricia R Houck

6

Patricia R Houck

0 references

Paolo Cassano

3

Paolo Cassano

0 references

Paola Rucci

5

Paola Rucci

0 references

author name string

Lorenzo Lattanzi

1

0 references

Alfredo Gemignani

7

0 references

Giulia Battistini

8

0 references

Annalisa Bassi

9

0 references

Giovanni B Cassano

Definition and epidemiology of treatment-resistant depression

11

0 references

language of work or name

English

0 references

publication date

October 2002

0 references

published in

Bipolar Disorders

0 references

volume

4

0 references

issue

5

0 references

page(s)

307-14

0 references

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Possible use of amantadine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Pramipexole as adjunct to haloperidol in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

Tricyclic nonresponders: phenomenology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

7 January 2021

The mesolimbic dopamine system as a target for rapid antidepressant action.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

7 January 2021

Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

7 January 2021

Bipolar depression and antidepressant-induced mania: a naturalistic study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

7 January 2021

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

7 January 2021